AU2001259747A1 - Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment - Google Patents

Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment

Info

Publication number
AU2001259747A1
AU2001259747A1 AU2001259747A AU5974701A AU2001259747A1 AU 2001259747 A1 AU2001259747 A1 AU 2001259747A1 AU 2001259747 A AU2001259747 A AU 2001259747A AU 5974701 A AU5974701 A AU 5974701A AU 2001259747 A1 AU2001259747 A1 AU 2001259747A1
Authority
AU
Australia
Prior art keywords
benzoxazinones
novel
treatment
activated receptor
peroxisome proliferator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259747A
Inventor
Thomas P. Burris
Philip J. Rybczynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2001259747A1 publication Critical patent/AU2001259747A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AU2001259747A 2000-05-12 2001-05-11 Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment Abandoned AU2001259747A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20385900P 2000-05-12 2000-05-12
US60203859 2000-05-12
US09/853,798 US6599899B2 (en) 2000-05-12 2001-05-11 Benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
PCT/US2001/015320 WO2001087860A2 (en) 2000-05-12 2001-05-11 Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
US09853798 2001-05-11

Publications (1)

Publication Number Publication Date
AU2001259747A1 true AU2001259747A1 (en) 2001-11-26

Family

ID=26898966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259747A Abandoned AU2001259747A1 (en) 2000-05-12 2001-05-11 Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment

Country Status (5)

Country Link
US (1) US6599899B2 (en)
EP (1) EP1280782A2 (en)
AU (1) AU2001259747A1 (en)
TW (1) TW200412347A (en)
WO (1) WO2001087860A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6908908B2 (en) * 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
WO2006102426A2 (en) * 2005-03-21 2006-09-28 Metabolex, Inc. Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders
CA2663121C (en) 2006-09-08 2016-01-19 Rhode Island Hospital Treatment, prevention, and reversal of alcohol-induced brain disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
WO1996004261A1 (en) 1994-07-29 1996-02-15 Smithkline Beecham Plc Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
US5696117A (en) 1995-11-07 1997-12-09 Ortho Pharmaceutical Corporation Benzoxazine antimicrobial agents
US5707990A (en) 1996-01-30 1998-01-13 Ortho Pharmaceutical Corporation 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
PL341795A1 (en) * 1998-05-27 2001-05-07 Reddy Research Foundation Bicycle compounds, process for obtaining them and pharmacological compositions containing such compounds

Also Published As

Publication number Publication date
TW200412347A (en) 2004-07-16
EP1280782A2 (en) 2003-02-05
WO2001087860A2 (en) 2001-11-22
WO2001087860A3 (en) 2002-03-28
US6599899B2 (en) 2003-07-29
US20020103193A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
IL158873A0 (en) Modulators of peroxisome proliferator activated receptors
AU7339800A (en) Ophthalmic device and method of manufacture and use
AU2197100A (en) Treatment of tooth surfaces and substance therefor
AU3917400A (en) Athletic apparatus and method of use
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
AU2741900A (en) Laminate-based apparatus and method of fabrication
AU2003205148A1 (en) Catheter hand-piece apparatus and method of using the same
AU2002330943A1 (en) Immunomodulatory compounds and methods of use thereof
AU2002234021A1 (en) Method and device for the treatment of vulnerable tissue site
AU2002361966A1 (en) Non-damaging fluid-loss control pill and method of using the same
AU3683800A (en) Device for the therapeutic and cosmetic photo-processing of biological tissues and method for using the same
AU2002301635A1 (en) Sunscreen emulsion composition and method of use
IL147503A0 (en) Oxazolidinone compounds and methods of preparation and use thereof
AU2002215261A1 (en) Method and arrangement for treatment of fluid
AU2003259717A1 (en) Modulators of rabggt and methods of use thereof
AU2003291700A1 (en) Oral hygiene system and method of treatment
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU3365401A (en) Use of ketotifen as ophthalmic agent
AU4649000A (en) Pressure relief device and method of using the same
AU2002326370A1 (en) Expandable polymer dental implant and method of use
AU3555200A (en) Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators
AU5800399A (en) Polish composition and method of use
AU2001259747A1 (en) Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
AU2001287198A1 (en) Dental restorative compositions and method of use thereof
AU2002367959A1 (en) Process for the preparation of oxazolidinones and method of use thereof